Drugs / arTreg
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03654040 | Apr 2021 → Mar 2023 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | arTreg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03654040 ↗ |
| Route | Intravenous | “Method of receipt: peripheral intravenous (IV) infusion, administered over 20 to 30 minutes.” NCT03654040 ↗ |